Dexmedetomidine for tear duct surgery
Treatments studied
Part of Eyes & vision clinical trials.
This study tests whether a medication called dexmedetomidine can reduce the amount of anesthesia needed during tear duct surgery (DCR), possibly making the procedure safer and more comfortable.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 16 and 75 years old.
- You are in overall good health or have mild to moderate health conditions (ASA class I, II, or III).
- You are scheduled for external dacryocystorhinostomy (DCR) surgery to treat a blocked tear duct.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding dexmedetomidine or magnesium sulfate to lidocaine makes numbing the eye more effective for tear-duct surgery. The goal is to find which combination provides better pain control during surgery.
This trial tests if a medicine called dexmedetomidine can help prevent agitation after nose surgery. You may be eligible if you are a healthy adult having planned nose surgery.
This study tests whether a sedation medicine called dexmedetomidine changes how much tears your eyes produce during an angioplasty procedure. If you are scheduled for an angioplasty and do not have existing dry eye problems, you may be eligible.
This trial tests adding dexmedetomidine (a calming medication) to bupivacaine (numbing medication) injected into the spine during knee surgery. The goal is to improve pain relief and recovery after surgery.
This trial tests adding a medicine called dexmedetomidine to the numbing IV used during knee surgery. It aims to see if it provides better pain relief after surgery under spinal anesthesia.
This study tests whether a medication given through the nose (dexmedetomidine) can help children stay calmer when waking up from eye-muscle surgery. Some children get very agitated or upset when coming out of anesthesia, and this medication might help prevent that.
Hear when a new Patients Undergoing External Dacrocystorhinostomy Operations trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.